This test is most useful if any of these apply to you.
If you flush, itch, get headaches, or feel gut symptoms after wine, aged cheese, or leftovers, but allergy tests keep coming back clean, this is the number that may finally explain the pattern. DAO (diamine oxidase) is the enzyme your gut uses to break down histamine in the food you eat, and when it runs low, histamine builds up and triggers reactions that look like allergies but are not.
This blood test gives you a direct read on how much of that breakdown enzyme is circulating. It is also informative in other contexts where gut lining damage, severe allergic reactions, or liver disease change DAO release into the blood. Levels are interpreted alongside symptoms and other tests rather than from a single cutoff.
DAO is made mostly in the lining of the small intestine, with smaller amounts produced by the placenta and kidney. Cells in the gut wall use the enzyme to break down histamine locally in the intestinal mucosa before it can enter circulation and cause symptoms. Only small amounts of DAO normally circulate in the bloodstream. When the intestinal lining is healthy and producing enough DAO, dietary histamine from fermented, aged, and cured foods is broken down on contact. When DAO production falls, histamine slips through and circulates.
This test measures the enzyme itself in your plasma, so it reflects two things at once: how much your gut is producing under normal conditions, and how much may be released acutely when the gut lining is irritated or damaged. That dual nature is why context matters so much when reading the result.
Histamine intolerance is the condition this test is most often used to evaluate. People with this pattern react to histamine-rich foods with flushing, hives, headaches, nasal congestion, diarrhea, or palpitations, but standard allergy testing comes back normal. In a study of symptomatic adults, those rated as having a high probability of histamine intolerance had lower median DAO levels than healthy controls. Histamine intolerance itself remains a debated entity that lacks fully standardized diagnostic criteria, so DAO should be read as one piece of evidence rather than a definitive test.
A separate retrospective study of 192 symptomatic outpatients found that lower DAO levels tracked with more severe symptoms, and that people with intermediate DAO levels had the most complex symptom patterns and the strongest response to a low-histamine diet and DAO supplementation. Circadian profiling of suspected histamine-intolerant patients identified a subgroup of about 24% with persistently reduced DAO activity and elevated plasma histamine, distinguishing them from food-allergic patients with similar complaints.
A large population survey of 1,051 adults found that a substantial portion had DAO below the suggested normal cutoff yet reported no symptoms after histamine-rich meals. The takeaway is that a low reading by itself does not make a diagnosis. The test is most informative when low DAO lines up with a recognizable symptom pattern.
When the intestinal lining is damaged, DAO leaks from injured cells into the bloodstream in larger amounts than usual, raising basal plasma levels. In a study of 69 people with inflammatory bowel disease compared with 30 healthy controls, basal plasma DAO was significantly higher in the IBD group and reflected the activity of disease. This is the same enzyme behaving as a marker of mucosal injury rather than enzyme abundance.
In gastric cancer patients on chemotherapy, declines in serum DAO activity preceded the onset of diarrhea, correlated with histologic damage to the gut lining, and predicted later drops in protein and albumin. Older work using a heparin-stimulated DAO test, which reflects functional enterocyte mass rather than basal circulating enzyme, showed reduced values in malabsorption, villous atrophy, and small-bowel Crohn's disease, with results that tracked inversely with disease activity. Basal plasma DAO and postheparin DAO are different measurements and can move in opposite directions in the same condition.
This test is not a simple higher-is-bad or lower-is-bad marker. Low DAO in someone with histamine-type symptoms suggests reduced enzyme production and a likely intolerance pattern. High DAO can mean something very different, often acute release from a damaged or activated gut, severe mast cell activation, or the natural surge of pregnancy. The right interpretation depends on whether you are looking at a baseline level in a stable person or a level measured during or after an acute event.
In a study of 135 patients with hepatitis B-related decompensated cirrhosis, elevated plasma DAO at discharge predicted 6-month hospital readmission and recurrent hepatic encephalopathy. DAO outperformed the standard Child-Pugh score for predicting these outcomes (area under the curve 0.769 vs 0.652). Early small studies have reported higher plasma DAO activity in children with severe asthma, with further rises during acute attacks, though this finding has not been broadly replicated and should be considered preliminary. Patients with chronic uremia have also shown increased plasma DAO.
During severe anaphylaxis in people with mastocytosis, plasma DAO can rise dramatically, with one study reporting an average 187-fold increase compared with baseline. The enzyme is thought to be released from gut storage sites when mast cells fire. Acutely high DAO in this context does not mean your everyday DAO is high. It reflects a specific event.
During normal pregnancy, plasma DAO rises sharply beginning around the seventh week of gestation, reaching levels roughly 100- to 290-fold higher than nonpregnant values in most women. Recent work shows the rise originates from extravillous trophoblasts in the placenta. Levels stay elevated until delivery, then fall over 10 to 14 days postpartum. A small exploratory study in 30 pregnant women with prior histamine intolerance found that pregnancy raised DAO activity roughly 11-fold and reduced symptoms, suggesting restrictive diets may not be needed during this period.
DAO is a context-dependent marker, and a single number is rarely the full story. The most useful approach is to get a baseline when you are well and free of acute illness, retest in 3 to 6 months if you are making meaningful changes (such as a low-histamine diet, gut healing protocols, or treatment for an underlying gut condition), and then at least annually to track your personal pattern.
A 3-week crossover study in histamine-intolerant patients found that short-term diet changes did not produce large or consistent shifts in DAO, suggesting the marker is relatively stable in the short term but may move slowly with sustained changes. Your own trend, measured across time and matched to how you feel, gives more clinical signal than any one reading compared to a population range.
Several situations can distort a single reading and lead you to the wrong conclusion:
Assay method also matters. Some labs measure DAO activity, others measure concentration, and the two are not interchangeable. Manufacturer labels vary in how they categorize results, so the number is best read alongside symptoms rather than against a single cutoff.
If your DAO comes back low and you have classic histamine intolerance symptoms, the practical next step is a structured 2 to 4 week trial of a low-histamine diet, ideally with food and symptom logging, and consideration of DAO enzyme supplementation taken before meals. Retest DAO at the end of the trial to see whether your number is moving. Companion testing worth considering includes plasma histamine, tryptase, and a workup to rule out classic allergic disease (specific IgE) and gut conditions that mimic histamine intolerance, such as celiac disease, lactose intolerance, and inflammatory bowel disease.
If your DAO is unexpectedly high and you are not pregnant, the question changes from histamine intolerance to what is releasing DAO. That conversation includes mast cell activation workup, liver and intestinal evaluation, and consideration of acute illness in the days before the draw. An allergist or gastroenterologist is the right specialist for either pattern, particularly when symptoms are severe, when symptoms do not improve on a low-histamine trial, or when systemic features (rashes, palpitations, persistent gut symptoms, unexplained anaphylaxis) are present.
Evidence-backed interventions that affect your DAO level
Diamine Oxidase is best interpreted alongside these tests.
Diamine Oxidase is included in these pre-built panels.